Beijing Scitop Bio Tech Co Ltd (300858) - Total Liabilities

Latest as of March 2026: CN¥169.53 Million CNY ≈ $24.81 Million USD

Based on the latest financial reports, Beijing Scitop Bio Tech Co Ltd (300858) has total liabilities worth CN¥169.53 Million CNY (≈ $24.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Beijing Scitop Bio Tech Co Ltd (300858) net asset momentum to track the company's year-over-year net asset growth rate.

Beijing Scitop Bio Tech Co Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Beijing Scitop Bio Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300858 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Beijing Scitop Bio Tech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Scitop Bio Tech Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
E&R Engineering
TWO:8027
Taiwan NT$1.49 Billion
Trilogy Metals Inc
TO:TMQ
Canada CA$33.06 Million
Hailir Pesticides and Chemicals Group Co Ltd
SHG:603639
China CN¥3.42 Billion
Jinxiandai Information Industry Co
SHE:300830
China CN¥116.33 Million
Flexium Interconnect Inc
TW:6269
Taiwan NT$13.05 Billion
Sage Therapeutics Inc
NASDAQ:SAGE
USA $54.19 Million
Markor International Home Furnishings Co Ltd
SHG:600337
China CN¥4.44 Billion
Satellogic V Inc
NASDAQ:SATL
USA $213.59 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Beijing Scitop Bio Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Scitop Bio Tech Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 7.73 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.08 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Scitop Bio Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Scitop Bio Tech Co Ltd (2015–2025)

The table below shows the annual total liabilities of Beijing Scitop Bio Tech Co Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥176.08 Million
≈ $25.77 Million
+39.71%
2024-12-31 CN¥126.03 Million
≈ $18.44 Million
+63.46%
2023-12-31 CN¥77.10 Million
≈ $11.28 Million
-17.97%
2022-12-31 CN¥93.99 Million
≈ $13.75 Million
+28.17%
2021-12-31 CN¥73.33 Million
≈ $10.73 Million
+10.01%
2020-12-31 CN¥66.66 Million
≈ $9.75 Million
+0.78%
2019-12-31 CN¥66.14 Million
≈ $9.68 Million
-8.02%
2018-12-31 CN¥71.91 Million
≈ $10.52 Million
+27.71%
2017-12-31 CN¥56.30 Million
≈ $8.24 Million
-21.46%
2016-12-31 CN¥71.69 Million
≈ $10.49 Million
-45.64%
2015-12-31 CN¥131.89 Million
≈ $19.30 Million
--

About Beijing Scitop Bio Tech Co Ltd

SHE:300858 China Biotechnology
Market Cap
$545.20 Million
CN¥3.73 Billion CNY
Market Cap Rank
#11651 Global
#3270 in China
Share Price
CN¥14.14
Change (1 day)
+1.58%
52-Week Range
CN¥13.03 - CN¥25.45
All Time High
CN¥35.93
About

Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women's health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy … Read more